RDY
Dr. Reddy’s Laboratories Ltd ADR
NYSE: RDY · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$13.43
+0.00% today
Updated 2026-06-05
Market cap
$11.13B
P/E ratio
24.76
P/S ratio
0.03x
EPS (TTM)
$0.54
Dividend yield
0.62%
52W range
$12 – $16
Volume
2.5M
Dr. Reddy’s Laboratories Ltd ADR (RDY) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$13.43
12-Month target
$13.43
2030 Target
$20.95
Intrinsic (DCF)
—
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $214.4B | $245.9B | $279.2B | $325.5B | $353.5B | $424.2B | $509.0B | $610.8B | $733.0B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 24.76x (capped 25x) · Margin: 12.80%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.